The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case Example. [electronic resource]
Producer: 20151214Description: 263-75 p. digitalISSN:- 1542-6270
- Antineoplastic Agents -- pharmacokinetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Trials, Phase III as Topic
- Drug Resistance, Neoplasm
- ErbB Receptors -- antagonists & inhibitors
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Mutation
- Prospective Studies
- Quinazolines -- pharmacokinetics
- Retrospective Studies
- Risk Assessment
- Technology Transfer
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.